Status:
UNKNOWN
Multimodal Analgesic Management of Naborphine Combined With Opioid Free Anesthesia in OSA Patients Undergoing Bariatric Surgery
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Analgesics，Opioid
Bariatric Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Comparative study to explore the effect of opioid free anesthesia technology in perioperative analgesia management, clarify the effect of naborphine instead of opioids on perioperative analgesia manag...
Detailed Description
1. The concept of enhanced recovery after surgery (ERAS) has been applied in the perioperative period of many operations. Reducing the dosage of opioids is an important part of the concept of ERAS. 2....
Eligibility Criteria
Inclusion
- ASA grade I \~ III;
- Age from 18 - 65 years old;
- BMI ≥ 35kg / m2 in patients with OSA to undergo bariatric surgery； （4 provide written informed consent for participation.
Exclusion
- Age \< 18 years or age \>65 years old;
- Pregnancy test was positive;
- Patients with a history of drug abuse or dependence on opioids;
- Patients with chronic pain or severe heart, lung, liver or nervous system diseases
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05386979
Start Date
May 15 2022
End Date
October 31 2023
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongtao Sun
Jinan, Shandong, China, 250000